相关实验视频
Updated: Jul 3, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
861
血清VEGF,P-选择素,HDL-C,血小板指数和凝血功能指数在创伤性骨折后深静脉血栓症中
Clinical laboratory
|February 12, 2024
概括
患有创伤性骨折并患有深静脉血栓症 (DVT) 的患者血清血管内皮生长因子 (VEGF) 和P-选择素较高,高密度脂蛋白胆固醇 (HDL-C) 较低. 这些标记物,以及血小板参数,有助于DVT诊断和风险评估.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 血管生物学 血管生物学
背景情况:
- 深静脉血栓症 (DVT) 是创伤性骨折后的一种严重并发症.
- 确定DVT风险分层的可靠生物标志物对于患者管理至关重要.
研究的目的:
- 研究血清血管内皮生长因子 (VEGF),P-选择素,高密度脂蛋白胆固醇 (HDL-C),血小板参数和凝血功能与创伤性骨折患者的DVT之间的关联.
- 在这个患者群体中识别DVT的潜在风险因素.
主要方法:
- 一项病例控制研究,涉及150名患有DVT的患者和150名没有DVT的患者在创伤性骨折后.
- 测量血清VEGF,P-选择因,HDL-C,血小板指数 (PLT,MPV,PDW,PCT,P-LCR) 和凝血功能 (TT,PT,APTT,FIB,D-D). 测量血清VEGF,P-选择因,HDL-C,血小板指数 (PLT,MPV,PDW,PCT,P-LCR),以及凝血功能 (TT,PT,APTT,FIB,D-D). 测量血清VEGF,P-选择因,HDL-C,血小板指数 (PLT,MPV,PDW,PCT,P-LCR),以及凝血功能 (TT,PT,APTT,FIB,D-D). 测量血清VEGF,P-选择因,HDL-C,血小板指数.
- 统计分析包括皮尔森的相关性和二进制后勤回归来确定风险因素.
主要成果:
- 与非DVT组相比,DVT组的血清VEGF和P-选择因水平显著更高.
- 在DVT组中,HDL-C水平显著降低.
- 血小板参数,特别是平均血小板体积 (MPV),血小板分布宽度 (PDW) 和血小板大细胞比率 (P-LCR),在DVT组显示水平下降.
- 多变量逻辑回归确定P-LCR是术后DVT的一个显著风险因素.
结论:
- 血清VEGF和P-选择因的升高和HDL-C的降低与创伤性骨折患者的DVT有关.
- 对VEGF,P-选择素,HDL-C和凝血标记物的联合评估可以改善DVT风险预测.
- 血小板参数 (MPV,PDW,P-LCR) 在诊断和评估DVT严重程度时具有临床价值.
相关概念视频
Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Clot Retraction and Fibrinolysis
5.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698
Coagulation
6.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.6K
Extrinsic and Intrinsic Pathways of Hemostasis
7.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.7K
Introduction to Hemostasis
7.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.7K

